Koligo Therapeutics, Inc.

Koligo Therapeutics, Inc.

 
 
 
 
 
 
 
 
 
 
 

Koligo Therapeutics, Inc.

2113 State Street
New Albany, IN 47150 | View on Google Maps
(502) 265-4830 | fax: (502) 265-4839
Connect With Us
FacebookTwitterLinkedInYouTube
Koligo Therapeutics, Inc. is a regenerative medicine company dedicated to the commercialization and development of transformative cell therapies for pancreatic diseases. KYSLECEL™ is available in the U.S. for the treatment of chronic or acute recurrent pancreatitis after total pancreatectomy. Koligo is developing a pipeline of other product candidates through the use of 3D bioprinting and other manufacturing advances.